Biliary Atresia Clinical Trial
Official title:
Search for Maternal Microchimerism in Swollen Portal Lymph Nodes of Infants With Biliary Atresia.
Maternal microchimerism has been discussed as an etiological mechanism in infantile
(perinatal) biliary atresia (BA). In Kasai's operation (resection of the liver hilum plaque
followed by hepato-portoenterostomy) surgeons frequently encounter swollen portal and
mesenteric lymph nodes.
Lymph nodes were sampled during Kasai' s operation and examined for maternal DNA.
Upon operation of infants with non-syndromatic biliary atresia (BA, commonest form),
surgeons almost invariably note the prominent finding of multiple swollen lymph nodes of up
to 2 cm in size in the porta hepatis and the small bowel mesentery where they may constitute
grape like complexes. Same-age infants laparotomized for other pathology commonly do not
present such nodes.
Biliary atresia is a disease of the newborn which is fatal when left untreated.
Histologically it corresponds to a degeneration of intra- und extra hepatic bile ducts
within a in part specific inflammatory infiltrate and progressive cirrhosis.
The etiology of this rare but constant disease (1:8-1:15.000) is unknown. Currently in BA
etiology research two main avenues are pursued:
1. Virally induced perinatal (auto)immune processes are suspected. An experimental form of
BA can be provoked by infecting murine mothers with dsRNA-viruses e.g.
Rhesus-rotaviruses or Reo-viruses while in mice, vaccination of mothers has prevented
experimental BA . The importance of the γ/δ-T-cell and IL17/IL 23 pathway , for BA is
currently probed. However, in groups of syngenic animals treated by the same batch of
viruses BA tends to be inconstant and it is limited to extrahepatic bile ducts such as
about the validity of the animal model is an issue.
2. The other direction of research does not primarily rely on experiments involving
newborn animals: There are indications that during pregnancy the placental barrier may
become permeable for maternal lymphocytes (e.g. by a faulty silencing of T-cell
attracting chemokines in decidual stroma cells) and already in 2008 maternal
lymphocytes have been demonstrated in livers of BA infants . Subsequently the
phenomenon of materno-fetal microchimerism has come into focus of BA ethiology
research: in the context of mixed materno-fetal immune reactions cells of maternal
origin could misdirect the immature immune system of the infant into auto-immunity or
act directly as effectors in a graft vs. host like fashion.
The importance of mesenteric and portal lymph nodes for maturation of the immune system
during pregnancy has been reported recently . Moreover it has been demonstrated that flow
the between liver and portal lymph nodes is bidirectional . In In mice the frequence of CD4+
and FoxP3+ regulatory T-cells was found to be linked to the mothers immune status. We thus
hypothesized that the prominently swollen lymph nodes of BA infants which surgeons
constantly encounter during Kasai's operation may hold a key to the better understanding of
pathophysiological important lymphocyte trafficking mechanisms.
In the standard operation, the Kasai-operation which in a race with increasing liver
cirrhosis makes sense up to an age of 4 months, the degraded rests of the major bile ducts
in the liver hilus (the so called "hilar plate") are resected, A Roux y-loop is sutured onto
the resection site. It shall drain any contingent bile flow from remaining bile ducts. The
long term success rate of this tentative of surgical cure which is of moderate technical
complexity and invasiveness is estimated to ca. 15-20%. In the remaining a partly sucess may
postpone the necessity of liver transplantation. We examined in seven consecutive patients
with histologically proven biliary atresia whether in periportal lymph nodes there was
evidence for maternal gentic material.
Methods :
7 consecutive patients with the preoperative diagnosis of BA were included in the study.
Other causes of icterus prolongatus (α1 anti-trypsin deficiency, Alagilles syndrom, PFIC
etc.) had been excluded amongst the methods technical successful ERCP (5/7 patients) which
showed absence of intrahepatic bile ducts.
After obtaining the parent's informed consent 2 ml EDTA whole blood were collected from
mother and infant. During Kasai's operation one portal and one mesenterial lymphnode were
sampled (Hannover Medical School ethical committee vote No.1650/11.12.2012. After bipolar
dissection the mesenteric gaps were closed with 4-0 Vicryl sutures.
Lymph nodes were disrupted mechanically and DNA was extracted enzymatically (QIAmp Kit,
Qiagen, Hilden/Germany) as described previously and normalized to 30 ug/ml.
Short tandem repeat analysis was realized with multiplex PCR for markers LIPOL, VWA, TH01,
D19S253, CSF, PLA2A. FGA, D21S11, D18S51 as described. Briefly, fragment length analysis was
performed an Abi Prism 310 System with GeneScan 3.11. software for comparison of mother's
and infant's blood with lymph node DNA.
Genetic single nucleotide polymorphisms (SNPs) were traced by quantitative real time PCR
chimerism analyses. Reactions were executed on an iCycler iQ5 real-time PCR platform
(Bio-Rad) using the ABsolute QPCR Rox Mix (Thermo scientific). Custom designed primers and
probes were provided by Sigma-Aldrich. Control reactions and normalization of sample DNA
were performed by amplifying the albumin gene.
;
Observational Model: Case Control, Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Enrolling by invitation |
NCT03667534 -
Dry Blood Spot Screening Test for Neonatal Cholestasis Patients
|
||
Completed |
NCT02652533 -
Ultrasound Shear Wave Elastography Evaluation of Suspected and Known Biliary Atresia
|
||
Completed |
NCT01443572 -
The Comparison of Desflurane and Sevoflurane on Postoperative Recovery and Hepatic Function of Biliary Atresia Patients During Kasai Operation
|
N/A | |
Recruiting |
NCT04373941 -
Part II: Granulocyte-Colony Stimulating Factor Adjunct Therapy for Biliary Atresia
|
Phase 2 | |
Completed |
NCT01854827 -
Safety Study of Intravenous Immunoglobulin (IVIG) Post-Portoenterostomy in Infants With Biliary Atresia
|
Phase 1/Phase 2 | |
Completed |
NCT00007033 -
Study of Magnesium Sulfate in Children With Reduced Bone Density Secondary to Chronic Cholestatic Liver Disease
|
N/A | |
Recruiting |
NCT05848310 -
Preoperative Serum FGF19 in the Prognosis of Biliary Atresia
|
||
Recruiting |
NCT05072626 -
High Medium-chain Triglyceride Nutritional Support in Infants With Biliary Atresia
|
||
Completed |
NCT00294684 -
A Randomized, Double-Blinded, Placebo-Controlled Trial of Corticosteroid Therapy Following Portoenterostomy
|
N/A | |
Active, not recruiting |
NCT02922751 -
FibroScan™ in Pediatric Cholestatic Liver Disease (FORCE)
|
||
Recruiting |
NCT06184971 -
Biliary Atresia Research Network Northeast
|
||
Recruiting |
NCT04260503 -
Gut Microbiome in Biliary Atresia
|
||
Not yet recruiting |
NCT06260566 -
Tolerability of Enteral NAC in Infants
|
Phase 1 | |
Completed |
NCT01322386 -
Gastrointestinal Microbiota in Primary Sclerosing Cholangitis and Biliary Atresia With Vancomycin
|
Phase 1 | |
Recruiting |
NCT05909033 -
Early Predictors for the Short Term Native Liver Survival in Patients With Biliary Atresia After Kasai Procedure
|
||
Completed |
NCT03499249 -
N-Acetylcysteine in Biliary Atresia After Kasai Portoenterostomy
|
Phase 2 | |
Recruiting |
NCT00345553 -
Biliary Atresia Study in Infants and Children
|
||
Recruiting |
NCT05521152 -
Norepinephrine for Prevention of Intraoperative Hypotension in Infants Undergoing Kasai Portoenterostomy
|
Phase 3 | |
Not yet recruiting |
NCT05783518 -
Effect of Desflurane on Pediatric Acute Respiratory Distress Syndrome After Living Donor Liver Transplant Recipients
|
Phase 4 | |
Not yet recruiting |
NCT06121375 -
Study to Assess Efficacy, Safety, Tolerability, Pharmacokinetics (PK), and Pharmacodynamics (PD) of Obeticholic Acid (OCA) Compared to Placebo in Pediatric Participants With Biliary Atresia, Post-hepatoportoenterostomy
|
Phase 2/Phase 3 |